<DOC>
	<DOCNO>NCT01466244</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor predict well patient respond treatment . PURPOSE : This research study study biomarkers patient metastatic recurrent head neck cancer treat cisplatin cetuximab ECOG-E5397 .</brief_summary>
	<brief_title>Biomarkers Patients With Metastatic Recurrent Head Neck Cancer Treated With Cisplatin Cetuximab ECOG-E5397</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare cetuximab activity , reflect response rate ( RR ) , PTEN-deficient PTEN-expressing cancer . Secondary - Examine RR , progression-free survival ( PFS ) , overall survival ( OS ) PTEN-deficient PTEN-expressing cancer , treatment arm . OUTLINE : Tissue microarray slide collect earlier ECOG-E5397 immunostained PTEN antibody analyze AQUA .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Treated protocol ECOGE5397 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma larynx</keyword>
	<keyword>stage IVA squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma larynx</keyword>
	<keyword>stage IVB squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVB squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma larynx</keyword>
	<keyword>stage IVC squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVC squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
</DOC>